Considering the anti-inflammatory impact of OXA/OX1R as just described, there are currently no data in the literature on the presence of the orexinergic complex in organs belonging to the male genital system, suffering from inflammatory diseases (i.e., prostatitis, orchitis, epididymitis). This evidence concerns the gene HCRTR1 and urogenital neoplasm.